In this issue:
- We announce an exciting development and marketing agreement for Novel CNS compounds with NTZ Labs
- Highlight fluorescent ligands via our University of Nottingham collaboration
- Introducing new CRISPR-Cas9 molecules available from BIONET/Key Organics
- Showcase a number of new exciting catalysts available from our Stockholm University collaboration
- A staff interview with Bonnie Ober
- Profile our event attendance at conferences and exhibitions this quarter
Click here to read the full newsletter
